22 related articles for article (PubMed ID: 21892090)
1. Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing.
Sharma A; Liu X; Chandra V; Rai R; Benbrook DM; Woo S
AAPS J; 2023 Dec; 26(1):5. PubMed ID: 38087107
[TBL] [Abstract][Full Text] [Related]
2. p53-guided response to nucleostemin loss in normal versus cancer cells.
Tsai RY
Cell Death Dis; 2015 Dec; 6(12):e2030. PubMed ID: 26720339
[No Abstract] [Full Text] [Related]
3. OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence.
Megiorni F; Camero S; Pontecorvi P; Camicia L; Marampon F; Ceccarelli S; Anastasiadou E; Bernabò N; Perniola G; Pizzuti A; Benedetti Panici P; Tombolini V; Marchese C
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33806232
[TBL] [Abstract][Full Text] [Related]
4. THAP11 Functions as a Tumor Suppressor in Gastric Cancer through Regulating c-Myc Signaling Pathways.
Zhang J; Zhang H; Shi H; Wang F; Du J; Wang Y; Wei Y; Xue W; Li D; Feng Y; Yan J; Gao Y; Li J; Han J
Biomed Res Int; 2020; 2020():7838924. PubMed ID: 32908912
[TBL] [Abstract][Full Text] [Related]
5. Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis.
Yuan F; Cheng Q; Li G; Tong T
PLoS One; 2015; 10(10):e0141678. PubMed ID: 26517370
[TBL] [Abstract][Full Text] [Related]
6. Nucleostemin: a latecomer with new tricks.
Tsai RY; Meng L
Int J Biochem Cell Biol; 2009 Nov; 41(11):2122-4. PubMed ID: 19501670
[TBL] [Abstract][Full Text] [Related]
7. Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms.
Kanter M; Turan G; Usta C; Usta A; Esen HH; Tavlı L; Celik C; Demirkol Y; Kanter B
J Mol Histol; 2016 Apr; 47(2):145-52. PubMed ID: 26815661
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
9. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
Barbieri F; Cagnoli M; Ragni N; Pedullà F; Foglia G; Alama A
Br J Cancer; 1997; 75(9):1263-8. PubMed ID: 9155044
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma.
Wu GQ; Xie D; Yang GF; Liao YJ; Mai SJ; Deng HX; Sze J; Guan XY; Zeng YX; Lin MC; Kung HF
Int J Cancer; 2009 Dec; 125(11):2631-42. PubMed ID: 19672860
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of nucleostemin expression and its correlation with cyclin D1 expression in malignant ovarian tumors.
Lin S; Yu HS
Int J Gynecol Cancer; 2011 Oct; 21(7):1166-71. PubMed ID: 21892090
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
